Given our ongoing research on the role of arginine methylation in gastric cancer [22, 23], we analyzed the expression of PRMT1 and PRMT5 in gastric cancer patients and found that their high expression was associated with poor prognosis (Fig. S2B). The gene discussed is PRMT5; the disease is gastric cancer.